One of the First RI Zantac Lawsuits Filed by Man Diagnosed with Bladder Cancer



Earlier this year, a Rhode Island man became one of the first individuals to file a lawsuit alleging that his use of Zantac over a five year period resulted in his bladder cancer diagnosis in October of 2019. Specifically, the complaint alleges that the Zantac he ingested was contaminated with N-Nitrosodimethylamine (NDMA) which, based on the prevailing scientific evidence, can cause bladder cancer in humans.


According to the complaints alleged in the Zantac lawsuit, the plaintiff alleged that he did not learn about the link between Zantac and bladder cancer until weeks before his diagnosis in September of 2019 when he saw a news article that was published indicating that high levels of NDMA had been found in Zantac medication. Although the Food and Drug Administration had found that Zantac contained a safe level of NDMA of 96 ng, testing that had been conducted by an independent Connecticut pharmacy Valisure detected that Zantac contamination may expose users to more than 3,000,000 ng per 150 mg pill of Zantac.


The full forty page complaint can be found here: Lane v. Boehringer Ingelheim Pharmaceuticals. The complaint was filed in the U.S. District Court for the District of Rhode Island on February 28th, 2020. The case is one of dozens of Zantac lawsuits filed in 2020 involving former users who indicate that they have been diagnosed with cancer following years of exposure to ranitidine. Plaintiffs in these lawsuits have also been diagnosed with stomach cancer, colorectal cancer, esophageal cancer, liver cancer, kidney cancer as well as other types of cancers of the digestive tract.


This Rhode Island Zantac lawsuit, along with others from around the entire country filed in the Federal Court system, have been ordered to be centralized and consolidated in the U.S. District for the Southern District of Florida by the U.S. Judicial Panel on Multidistrict Litigation. In the U.S. District Court for the Southern District of Florida coordinated discovery and pretrial proceedings are being overseen by U.S. District Judge Robin L. Rosenberg.

If you or a loved one has been diagnosed with cancer, including stomach cancer, colorectal cancer, esophageal cancer, liver cancer, kidney cancer, or any other type of cancer of the digestive tract, after using Zantac, please contact our Zantac lawyers at Marin and Barrett, Inc. for a no obligation, free case consultation and evaluation. Our attorneys are available 24/7 to discuss your situation, diagnosis, and possible claims in the Zantac litigation. We can be reached at 888-384-2735 or by filling out a contact form on our website: https://www.marinbarrettlaw.com/contact-us.

personal injury lawyers.jpg

Office Locations

RHODE ISLAND

127 Dorrance Street

Providence, RI 02903

(401) 380-6724

58 Main Street
East Greenwich, RI 02818

(401) 228-8271

36 South County Commons Way

South Kingstown, RI 02879

(401) 594-8001

37 Bellevue Avenue

Newport, RI 02840

(401) 218-0034

CONNECTICUT

1 Bradley Road

Suite 201

Woodbridge, CT 06525

(203) 285-8167

Copyright © 2020 by Marin and Barrett, Inc.

 

               Marin and Barrett, Inc.

Rated 5 out of 5 based on

207 Google Reviews

M&B Blog   |   Terms of Use   |   Privacy Policy   |   Anti-Spam

  • Rhode Island Personal Injury Lawyers Twitter Profile
  • Rhode Island Personal Injury Lawyers Instagram Profile
  • Rhode Island Personal Injury Lawyers Facebook Page
  • YouTube
  • RSS

DISCLAIMER: This site and any information contained herein are intended for informational purposes only and should not be construed as legal advice. Seek competent legal counsel for advice on any legal matter. Also, the Rhode Island Supreme Court licenses all lawyers in the general practice of law, but does not license or certify any lawyer as an expert or specialist in any field of practice.  The verdicts and settlements listed on this site are intended to be representative of cases handled by Marin and Barrett, Inc. These listings are not a guarantee or prediction of the outcome of any other claims.